Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915103 · ClinicalTrials.gov registry record
A Case Report of NMDAR Encephalopathy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1
- Enrollment target
NCT06915103: Completed study, sponsored by Mayo Clinic.
NCT06915103 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06915103 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI)
- PROCEDURE Salpingo-oophorectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-06-20 |
| Est. Completion | 2024-12-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915103
The ClinicalTrials.gov registry entry for NCT06915103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT06915103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06915103 about?
NCT06915103 is a clinical study titled "A Case Report of NMDAR Encephalopathy". This case illustrates the clinical, radiologic, and histopathologic features of Anti-NMDAR encephalitis and underscores the importance of MRI in detecting ovarian teratomas when pelvic ultrasound is inconclusive.
What is the current status of trial NCT06915103?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2024-06-20. Estimated completion is 2024-12-19.
What interventions are being tested in trial NCT06915103?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Salpingo-oophorectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06915103?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.